通过NMN的管理来改善 lysosomal ferroptosis,可以预防心力衰竭
Mikako Yagi1,2, Yura Do1, Haruka Hirai1,2
1Department of Clinical Chemistry and Laboratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Life science alliance
|October 4, 2023
概括
尼古丁胺胺 mononucleotide (NMN) 补充剂通过增强 lysosomal 功能和自,而不是线粒体功能,改善了小鼠的心力衰竭. 这种干预减少了铁亡并延长了扩张性心肌病症的小鼠模型的寿命.
科学领域:
- 心血管生物学 心血管生物学
- 线粒体医学 线粒体医学
- 细胞的新陈代谢
背景情况:
- 线粒体对心脏能量代谢至关重要,它们的功能障碍与心脏疾病有关.
- 心肌细胞中的线粒体翻译缺陷可能导致心力衰竭,自功能受损和NAD+水平降低.
- 减少的NAD+会影响 lysosomal 功能,导致心脏病理.
研究的目的:
- 调查尼古丁胺胺单核酸 (NMN) 管理是否可以改善因线粒体功能障碍引起的心力衰竭.
- 在p32淘汰赛小鼠模型中探索NMN影响心脏健康的特定机制.
主要方法:
- 使用小鼠模型,对线粒体转化因子p32 (p32cKO) 进行心肌细胞特异性淘汰.
- 给p32cKO小鼠注射NMN,以评估其对心脏功能,溶酶体健康,自和铁亡的影响.
- 分析了溶酶体损伤,铁积累,脂质过氧化和自标志物.
主要成果:
- 在p32cKO小鼠中,NMN的使用减少了溶酶体损伤和改善了自,减轻了心力衰竭和延长了寿命.
- mitochondrial 功能障碍诱导的 lysosomal 损伤被发现通过铁积累和脂质过氧化触发铁.
- NMN的有益作用主要与改善 lysosomal 功能有关,特别是预防 lysosome-mediated ferroptosis,而不是直接增强线粒体.
结论:
- 补充NMN可以通过改善 lysosomal 功能和自来预防慢性心力衰竭,而不是直接增强线粒体功能.
- 向溶酶体功能障碍和铁亡是一种有前途的治疗策略,用于与线粒体缺陷相关的心力衰竭.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
601
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
601
01:30Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
445
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
445
01:16Necrosis
4.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
01:29Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K